Hepatitis B Virus Carrier Status Linked to Autoimmune Hepatitis

スポンサーリンク

概要

• 論文の詳細を見る

• We describe a hepatitis B virus carrier who satisfied the criteria of autoimmune hepatitis proposed by the International Autoimmune Hepatitis Group. A 43-year-old Japanese female showed human leukocyte antigen typing including DR4 in addition to hypergammaglobulinemia, presence of autoantibodies, and liver histology suggestive of autoimmune hepatitis. Moreover, the predominant presence of hepatitis B core antigen in nuclei rather than in cytoplasm of hepatocytes suggested less of a possibility of liver cell damage related to hepatitis B virus infection. She completely responded to immunosuppressive therapy and no clinical or biochemical relapse has been recognized to date.(Internal Medicine 35: 468-471, 1996)

• 社団法人 日本内科学会の論文

著者

• HINO Keisuke

  Yamaguchi University School of Medicine

• Okita Kiwamu

  下関厚生病院(社保)

• Ohkawa Kazuyoshi

  大阪大学

• Ogata Kei

  The Second Department Of Medicine Division Of Kidney Disease And Critical Care Medicine Kurume Unive

• Fujii Kaori

  First Department Of Internal Medicine Yamaguchi University School Of Medicine

• Hino K

  First Department Of Internal Medicine Yamaguchi University School Of Medicine Saiseikai Shimonoseki

• Hino Keisuke

  First Department Of Internal Medicine Yamaguchi University School Of Medicine

• Hino Keisuke

  Department Of Biology Faculty Of Science Kohnan Universtiy:(present Address) Institute Of Advanced E

• Hino Keisuke

  Department Of Gastroenterology And Hepatology Yamaguchi University School Of Medicine

• OKAZAKI Muneko

  Department of Gastroenterology and Hepatology, Yamaguchi University, School of Medicine

• Okita Kiwamu

  Department Of Gastroenterology And Hepatology Yamaguchi University Graduate School Of Medicine

• Okita K

  Yamaguchi Univ. Yamaguchi Jpn

• Omori Kaoru

  Department Of Molecular Science & Applied Medicine (gastroenterology & Hepatology) Yamaguchi

• MURAKAMI Chisa

  First Department of Internal Medicine, yamaguchi University, School of Medicine

• Okuda Michiaki

  First Department Of Internal Medicine Yamaguchi University School Of Medicine Shimonoseki Central Ho

• Murakami Chisa

  First Department Of Internal Medicine Yamaguchi University School Of Medicine

• Okazaki Muneko

  First Department Of Internal Medicine Yamaguchi University School Of Medicine

• Hino Keisuke

  Department Of Laboratory Sciences Yamaguchi University School Of Medicine

• Fujii K

  Third Department Of Internal Medicine Saitama Medical School

• Hanada Hiroshi

  The First Department Of Internal Medicine Yamaguchi University School Of Medicine

• MURAKAMI Chisa

  the First Department of Internal Medicine, Yamaguchi University, School of Medicine

• HINO Keisuke

  the First Department of Internal Medicine, Yamaguchi University, School of Medicine

• OKAZAKI Muneko

  the First Department of Internal Medicine, Yamaguchi University, School of Medicine

• FUJII Kaori

  the First Department of Internal Medicine, Yamaguchi University, School of Medicine

• OKUDA Michiari

  the First Department of Internal Medicine, Yamaguchi University, School of Medicine

• YAMASAKI Takahiro

  the First Department of Internal Medicine, Yamaguchi University, School of Medicine

• OKITA Kiwamu

  the First Department of Internal Medicine, Yamaguchi University, School of Medicine

• Okuda Michiari

  Department Of Gastroenterology And Hepatology Yamaguchi University School Of Medicine

• Yamasaki Takahiro

  The First Department Of Internal Medicine Yamaguchi University School Of Medicine

• OKITA Kiwamu

  The First Department of Internal Medicine, Yamaguchi University School of Medicine

関連論文

• Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
• Granulocytapheresis (GCAP) for severe alcoholic hepatitis-A preliminary report
• Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
• Timing of interferon therapy and sources of infection in patients with acute hepatitis C
• Clinical course of patients with chronic hepatitis B with viral breakthrough during long-term lamivudine treatment
• Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis
• Prolyl 4-hydroxylase inhibitor is more effective for the inhibition of proliferation than for inhibition of collagen synthesis of rat hepatic stellate cells
• HBV-related fulminant hepatic failure : successful intensive medical therapy in a candidate for liver transplantation
• Characteristics of the cell proliferation profile of activated rat hepatic stellate cells in vitro in contrast to their fibrogenesis activity
• Interferon γ- but not α-treatment prevents fibrosis by inhibiting procollagen and tissue inhibitor of metalloproteinase-1 gene expression in pig serum-induced rat liver fibrosis in vivo
• Fulminant hepatitis complicated by small intestine infection and massive hemorrhage
• Novel arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma
• Lamivudine-to-entecavir switching treatment in type B chronic hepatitis patients without evidence of lamivudine resistance
• Factors contributing to antiviral effect of adefovir dipivoxil therapy added to ongoing lamivudine treatment in patients with lamivudine-resistant chronic hepatitis B
• Serum levels of soluble major histocompatibility complex (MHC) class I-related chain A in patients with chronic liver diseases and changes during transcatheter arterial embolization for hepatocellular carcinoma
• Early emergence of entecavir-resistant hepatitis B virus in a patient with hepatitis B virus/human immunodeficiency virus coinfection
• Initial viral response is the most powerful predictor of the emergence of YMDD mutant virus in chronic hepatitis B patients treated with lamivudine
• Interferon therapy for aged patients with chronic hepatitis C : improved survival in patients exhibiting a biochemical response
• A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
• Changes in gene expression profile by HCV core protein in cultured liver cells : analysis by DNA array assay
• Assay of DNA Photolyase Activity in Spinach Leaves in Relation to Cell Compartmentation-Evidence for Lack of DNA Photolyase in Chloroplasts
• Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species
• In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C : correlation with hepatic steatosis
• Hepatitis C virus infection upregulates expression of the type I interferon receptor in human peripheral blood mononuclear cells
• Hepatic expression of type I interferon receptor for predicting response to interferon therapy in chronic hepatitis C patients : a comparison of immunohistochemical method vs. competitive polymerase chain reaction assay
• Hepatitis viral infection in Behcet's disease
• A modified Japan Integrated Stage score for prognostic assessment in patients with hepatocellular carcinoma
• Interferon-γ brings additive anti-viral environment when combined with interferon-α in patients with chronic hepatitis C
• Detection of hepatitis B virus DNA in liver by polymerase chain reaction for the diagnosis of fulminant hepatitis B
• One-point quantitative determination of pretreatment serum hepatitis C virus RNA predicts long-term responsiveness to high-dose interferon therapy
• Intrahepatic hepatitis C virus RNA levels after interferon treatment: eradication of the minus-strand RNA correlates with sustained remission of hepatitis
• Hepatitis B virus genotype G is an extremely rare genotype in Japan
• Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis
• Efficacy of interferon alfacon-1 daily induction therapy followed by three-times weekly therapy in patients with chronic hepatitis C virus infection with high and low viral titers
• Involvement of GBV-C/HGV in liver diseases in Japan
• Therapeutic effect of secretin in patients with jaundice; Double-blind placebo-controlled multicentric trial
• D-Penicillamine improved laparoscopic and histological findings of the liver in a patient with Wilson's disease : 3-year follow-up after diagnosis of Coombs-negative hemolytic anemia of Wilson's disease
• Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma
• Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy
• Arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and isovorin for patients with advanced hepatocellular carcinoma, pilot study : Is a high dose of the biochemical modulator effective?
• Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan
• Comparative genomic hybridization analysis for pancreatic cancer specimens obtained by endoscopic ultrasonography-guided fine-needle aspiration
• Wild-type p53 gene-induced morphological changes and growth suppression in hepatoma cells
• Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the rat
• Effects of the elevation of serum bile acids on gastric mucosal damage
• New Inuyama classification; new criteria for histological assessment of chronic hepatitis^1
• α-Fetnprotein Containing Cells in Early Stages during Hepatocarcinogensis in Rats Fed 2－Acetylaminofluorene
• Short term and two-step interferon therapy for chronic hepatitis C patients with low HCV RNA levels
• Transcription-mediated amplification is more useful in the follow-up of patients with chronic hepatitis B treated with lamivudine
• Antioxidant, N-acetyl-L-cysteine inhibits the expression of the collagen α2 (I) promoter in the activated human hepatic stellate cell line in the absence as well as the presence of transforming growth factor-β
• Th1 down-regulation at the single-lymphocyte level in HCV-related liver cirrhosis and the effect of TGF-β on Th1 response : possible implications for the development of hepatoma
• A Case of Safe Endoscopic Removal of a Gastric Bezoar
• Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer
• Association of the -173G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis
• Polymorphisms of the IL-1β and IL-1β-inducible genes in ulcerative colitis
• Saikosaponin A-induced cell death of a human hepatoma cell line (HuH-7) : The significance of the 'sub-G_1 peak' in a DNA histogram
• Induction to Granulocytic Differentiation of Human Promyelocytic Leukemia Cells （HL－6０） by Polyprenoic Acid （E5166）
• High MDM2 mRNA expression in hepatoblastoma cell-lines
• Effects on liver functions of gastric variceal therapy by endoscopic ligation using a detachable snare and sclerotherapy with O-ring ligation
• Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase
• Ulcerative Colitis complicated by a Leaked Colojejunal Fistula: Report of a Case
• Prolyl 4-hydroxylase inhibitor (HOE 077) prevents TIMP-1 gene expression in rat liver fibrosis
• Treatment of Hepatocellular Carcinoma by Inter-arterial Infusion with Mitomycin C
• Clinical evaluation of chronic liver diseases induced by different hepatitis C virus genotype in Japan, focused on the difference between genotypes III/2a and IV/2b
• Cytochrome c is a possible new marker for fulminant hepatitis in humans
• Effect of a late evening snack using branched-chain amino acid-enriched nutrients in patients undergoing hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
• Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma : Is the addition of subcutaneous interferon-α-2b beneficial?
• Screening of hepatocellular cancer : Japanese strategy
• Development of cell therapy using autologous bone marrow cells for liver cirrhosis
• Lesson from the GFP/CCl4 model - Translational Research Project : the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis
• Rupture of peritoneal metastatic tumor that developed due to needle-tract implantation of hepatocellular carcinoma
• The effect of a late evening snack in patients with liver cirrhosis
• Late evening snack and the change of blood glucose level in patients with liver cirrhosis
• An In Vivo Model for Monitoring Trans-Differentiation of Bone Marrow Cells into Functional Hepatocytes
• A new cell therapy using bone marrow cells to repair damaged liver
• Evaluation of power Doppler imaging in the management of small liver cancer
• Percutaneous hot water injection and microwave coagulation therapy for small hepatocellular carcinoma
• Changes of depolymerized and polymerized tubulin proteins in the liver after taurocholic acid administration with or without colchicine pretreatment and cholestasis due to cytochalasin B and bile duct ligation in rats
• Protection by glycine against chemical ischemia produced by cyanide in cultured hepatocytes
• The effect of E3330 on active oxygen generation by isolated hepatic macrophages in rats
• Percutaneous hot water injection therapy (PHoT) for treatment of hepatocellular carcinoma: a comparision with percutaneous ethanol injection therapy (PEIT)
• Management of hepatitis C ; Report of the Consensus Meeting at the 45th Annual Meeting of the Japan Society of Hepatology (2009)
• Immunohistochemical study study of Fas antigen in liver of Patients with chronic hepatitis and autoimmune liver disease
• A case of Primary Biliary Cirrhosis with Benefucial Effect of Secrerin in the Treatment of Jaundice - with a Study of Secretin Induced Choloresis in Man-
• A Case Report of Seuretin Therapy for Primary Sclerosing Cholangitis
• Hepatocellular carcinoma with Hemobilia and Obstructive Jaundice
• Hepatitis B Virus Carrier Status Linked to Autoimmune Hepatitis
• "Rebound" phenomenon of hepatitis C viremia after interferon therapy in "relapsed" patients with chronic hepatitis C
• Molecular Pathogenesis of Viral Hepatitis
• A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis
• Absence of invariant natural killer T cells deteriorates liver inflammation and fibrosis in mice fed high-fat diet
• Cell Death Induced by Baicalein in Human Hepatocellular Carcinoma Cell Lines
• GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION)
• Risk factors for hepatocellular carcinoma in Japanese patients with autoimmune hepatitis type 1
• Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients
• Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy
• Abducent Nerve Paralysis during Interferon Alpha-2a Therapy in a Case of Chronic Active Hepatitis C.

もっと見る 閉じる

スポンサーリンク